Medline initiated with an Outperform at Wolfe Research

Wolfe Research initiated coverage of Medline (MDLN) with an Outperform rating and $47 price target In the U.S. medical and surgical supplies category, Medline has product and distribution scale “without rival,” says the analyst, who adds that over the long term there are “more ponds for MDLN to fish, or fish harder.”